Wan‐Long Chuang

Active 1990–2025

Also published as
Wan-Long Chuang
156
Papers
17,964
Citations
69
h-index
137
i10-index

Citations

Citations per year for Wan‐Long Chuang1992: 1 citations1994: 1 citations1995: 10 citations1996: 6 citations1997: 5 citations1998: 1 citations1999: 8 citations2000: 11 citations2001: 7 citations2002: 4 citations2003: 5 citations2004: 3 citations2005: 16 citations2006: 13 citations2007: 17 citations2008: 25 citations2009: 36 citations2010: 45 citations2011: 58 citations2012: 50 citations2013: 61 citations2014: 59 citations2015: 89 citations2016: 89 citations2017: 112 citations2018: 164 citations2019: 619 citations2020: 705 citations2021: 670 citations2022: 473 citations2023: 376 citations2024: 693 citations2025: 336 citations2026: 6 citations1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,147 citing papers, 15.8% of this breakdownChina: 826 citing papers, 11.4% of this breakdownTaiwan: 449 citing papers, 6.2% of this breakdownUnited Kingdom: 364 citing papers, 5% of this breakdownItaly: 315 citing papers, 4.3% of this breakdownJapan: 285 citing papers, 3.9% of this breakdownFrance: 279 citing papers, 3.9% of this breakdownGermany: 269 citing papers, 3.7% of this breakdownAustralia: 265 citing papers, 3.7% of this breakdownCanada: 250 citing papers, 3.5% of this breakdownSpain: 221 citing papers, 3% of this breakdownSouth Korea: 193 citing papers, 2.7% of this breakdown
0%15.8%Other 32.9%

Fields

  • Medicine88.1%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Immunology and Microbiology1.8%
  • Neuroscience0.9%
  • Computer Science0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.8%

Topics

  • Hepatitis C virus research20%
  • Hepatitis B Virus Studies17.1%
  • Liver Disease Diagnosis and Treatment13.5%
  • Hepatitis Viruses Studies and Epidemiology4.1%
  • Hepatocellular Carcinoma Treatment and Prognosis3.1%
  • HIV/AIDS drug development and treatment2.6%
  • Other39.6%

Coauthors

All papers

Open in search
  1. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ziv Ben‐Ari, Fernando Bessone, Mia J. Biondi, Abdul Rahman Bizri, Carlos Eduardo Brandão‐Mello, Krestina Brigida, Kimberly Brown, Robert S. Brown, Philip Bruggmann, Maurizia Rossana Brunetto, Dana Busschots, Marı́a Buti, Maia Butsashvili, Joaquín Cabezas, Chungman Chae, Viktorija Chaloska Ivanova, Henry Lik‐Yuen Chan, Hugo Cheinquer, Kent Jason G. Cheng, Myeong-Eun Cheon, Cheng‐Hung Chien, Rong‐Nan Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan‐Long Chuang, Vladimir Chulanov, Laura Cisneros, B. Coco, Fernando A Contreras, Markus Cornberg, Matthew Cramp, Javier Crespo, Fuqiang Cui, Chris Cunningham, Lucy Dagher Abou, Olav Dalgård, Doan Y Dao, Victor de Lédinghen, Moutaz Derbala, Keshab Deuba, Karan Dhindsa, Samsuridjal Djauzi, Sylvia Dražilová, Ann‐Sofi Duberg, Mohammed Elbadri, Manal H. El‐Sayed, Gamal Esmat, Chris Estes, Sameera Ezzat, Martti Färkkilâ, Laurent Ferradini, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Tajana Filipec Kanižaj, Robert Flisiak, Soňa Fraňková, James Fung, Amiran Gamkrelidze, Edward Gane, Virginia Garcia, Javier García‐Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe, Pierre M. Gholam, Adrian Goldis, Magnús Gottfreðsson, Richard T. Gray, Jason Grebely, Michael Gschwantler and 158 more - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 653

  2. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Abdul R Bizri, Sarah Blach, Carlos E Brandão Mello, Samantha M Brandon, Bisi Bright, Philip Bruggmann, Maurizia Brunetto, Maria Buti, Henry L Y Chan, Asad Chaudhry, Rong-Nan Chien, Moon S Choi, Peer B Christensen, Wan-Long Chuang, Vladimir Chulanov, Mette R Clausen, Massimo Colombo, Markus Cornberg, Benjamin Cowie, Antonio Craxi, Esther A Croes, Diego Alberto Cuellar, Chris Cunningham, Hailemichael Desalegn, Sylvia Drazilova, Ann-Sofi Duberg, Steve S Egeonu, Manal H El-Sayed, Chris Estes, Karolin Falconer, Maria L G Ferraz, Paulo R Ferreira, Robert Flisiak, Sona Frankova, Giovanni B Gaeta, Javier García-Samaniego, Jordan Genov, Jan Gerstoft, Adrian Goldis, Ilias Gountas, Richard Gray, Mário Guimarães Pessôa, Behzad Hajarizadeh, Angelos Hatzakis, Christophe Hézode, Sayed M Himatt, Andy Hoepelman, Irena Hrstic, Yee-Tak T Hui, Petr Husa, Rohani Jahis, Naveed Z Janjua, Peter Jarčuška, Jerzy Jaroszewicz, Sabahattin Kaymakoglu, David Kershenobich, Loreta A Kondili, Aliya Konysbekova, Mel Krajden, Pavol Kristian, Wim Laleman, Wai-cheung C Lao, Jen Layden, Jeffrey V Lazarus, Mei-Hsuan Lee, Valentina Liakina, Young-Suk S Lim, Ching-kong K Loo, Boris Lukšić, Reza Malekzadeh and 96 more - ˜The œLancet. Gastroenterology & hepatology 2018 cited by 1,737

  3. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amarsanaa Jazag, Motswedi Anderson, Monique Andersson, Paige Armstrong, Tarik Asselah, Kostas Athanasakis, Oidov Baatarkhuu, Ziv Ben‐Ari, Aïcha Bensalem, Fernando Bessone, Mia Biondi, Abdul Rahman Bizri, Sarah Blach, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Carol Brosgart, Kimberly Brown, Robert Brown, Jr, Philip Bruggmann, Maurizia Brunetto, Maria Buti, Joaquin Cabezas, Teresa Casanovas, Chungman Chae, Henry Lik Yuen Chan, Hugo Cheinquer, Pei-Jer Chen, Kent Jason Cheng, Myeong-Eun Cheon, Cheng-Hung Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan-Long Chuang, Vladimir Chulanov, Laura Cisneros, Carla Coffin, Fernando Contreras, Nicola Coppola, Markus Cornberg, Benjamin Cowie, Matthew Cramp, Antonio Craxi, Javier Crespo, Fuqiang Cui, Chris Cunningham, Olav Dalgard, Robert De Knegt, Victor De Ledinghen, Gregory Dore, Sylvia Drazilova, Ann-Sofi Duberg, Steve Egeonu, Mohammed Elbadri, Mohamed El-Kassas, Manal El-Sayed, Chris Estes, Ohad Etzion, Elmobashar Farag, Laurent Ferradini, Paulo Ferreira, Robert Flisiak, Xavier Forns, Sona Frankova, James Fung, Edward Gane, Virginia Garcia, Javier García-Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe and 169 more - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 404

  4. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Abdullah M. Assiri, Oidov Baatarkhuu, Abate Bane, Ziv Ben‐Ari, Colm Bergin, Fernando Bessone, Florian Bihl, Abdul Rahman Bizri, Martin Blachier, Antonio Javier Blasco, Carlos Eduardo Brandão‐Mello, Philip Bruggmann, Cheryl Brunton, Filipe Calinas, Henry Lik‐Yuen Chan, Asad Chaudhry, Hugo Cheinquer, Chien‐Jen Chen, Rong‐Nan Chien, Moon Seok Choi, Peer Brehm Christensen, Wan‐Long Chuang, Vladimir Chulanov, Laura Cisneros, Mette Rye Clausen, Matthew Cramp, Antonio Craxı̀, Esther A. Croes, Olav Dalgård, Jorge Daruich, Victor de Lédinghen, Gregory J. Dore, Manal H. El‐Sayed, Gül Ergör, Gamal Esmat, Chris Estes, Karolin Falconer, Elmoubasher Farag, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Robert Flisiak, Soňa Fraňková, Ivane Gamkrelidze, Ed Gane, Javier García‐Samaniego, Amir Ghafoor Khan, Ilias Gountas, Adrian Goldis, Magnús Gottfreðsson, Jason Grebely, Michael Gschwantler, Mário Guimarães Pessôa, J. Gunter, Behzad Hajarizadeh, O. Hajelssedig, Saeed Hamid, Waseem Hamoudi, Angelos Hatzakis, Sayed Himatt, Harald Hofer, Irena Hrstić, Yee-Tak Hui, Béla Hunyady, Ramazan Idılman, Wasim Jafri, Rohani Jahis, Naveed Z. Janjua, Peter Jarčuška, Agita Jēruma, Jón G. Jónasson and 122 more - ˜The œLancet. Gastroenterology & hepatology 2016 cited by 2,032

  5. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2016 cited by 458

  6. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2018 cited by 423

  7. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2016 cited by 546

  8. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ramsey Cheung, Seng Gee Lim, Huy N. Trinh, Wan‐Long Chuang, Yasuhito Tanaka, Hidenori Toyoda, Ming‐Lung Yu, Mindie H. Nguyen - Hepatology 2023 cited by 89

  9. First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients

    Authors: , , , , , , , , , , , , , , , , , - Hepatology International 2021 cited by 63

  10. Modelling NAFLD disease burden in four Asian regions—2019‐2030

    Authors: , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2020 cited by 169

  11. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Berg, Mia J. Biondi, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Robert S. Brown, Maurizia Rossana Brunetto, Joaquín Cabezas, Mariana Cardoso, Alexandra Martins, Henry Lik‐Yuen Chan, Hugo Cheinquer, C.-J. Chen, Hwai‐I Yang, Pei‐Jer Chen, Cheng‐Hung Chien, Wan‐Long Chuang, L. Cisneros Garza, B. Coco, Carla S. Coffin, Nicola Coppola, Markus Cornberg, Antonio Craxı̀, Javier Crespo, Liri Çuko, Victor de Lédinghen, A.‐S. Duberg, Ohad Etzion, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Xavier Forns, Graham R. Foster, James Fung, Giovanni Battista Gaeta, Javier García‐Samaniego, J Genov, Liliana Gheorghe, Patrick Gholam, Robert G. Gish, Jeffrey S. Glenn, Saeed Hamid, Julian Hercun, Yao‐Chun Hsu, Chih-Chien Hu, Jee‐Fu Huang, Ramazan Idılman, Wasim Jafri, Naveed Z. Janjua, Deian Jelev, Jidong Jia, Martin Kåberg, Kelly Kaita, Jia‐Horng Kao, Aamir Khan, Do Young ‍Kim, Loreta A. Kondili, Martin Lagging, Pietro Lampertico, Pablo Lázaro, Jeffrey V. Lazarus, M.-H. Lee, Hwai‐I Yang, Young‐Suk Lim, Cirley Lobato, Guilherme Macedo, Rui Tato Marinho, Paul Marotta, Maria Cássia Mendes-Corrêa, Nahúm Méndez‐Sánchez, M.-C. Navas, Qing Ning and 42 more - Journal of Hepatology 2023 cited by 95

  12. Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes

    Authors: , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2024 cited by 43

  13. Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean-Dean Liu, Tzeng-Huey Yang, Gin‐Ho Lo, Ming-Hung Tsai, Chang-Hua Chou, Yeong‐Shan Cheng - Gastroenterology 2016 cited by 251

  14. Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC

    Authors: , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2024 cited by 42

  15. Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2015 cited by 338

  16. Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jens Kort, Bo Fu, Ran Liu, Teresa I. Ng, Tami Pilot-Matias, Chih‐Wei Lin, Roger Trinh, Federico Mensa - New England Journal of Medicine 2018 cited by 437

  17. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2020 cited by 139

  18. Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vedran Pavlovic, Bernadette Surujbally, Miriam Triyatni, Ruchi Upmanyu, Cynthia Wat, Edward Gane - New England Journal of Medicine 2024 cited by 69

  19. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicola Coppola, Antonio Craxı̀, Javier Crespo, Victor de Lédinghen, Ann‐Sofi Duberg, Ohad Etzion, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Xavier Forns, Graham R. Foster, Giovanni Battista Gaeta, Ivane Gamkrelidze, Javier García‐Samaniego, Liliana Gheorghe, Pierre M. Gholam, Robert G. Gish, Jeffrey S. Glenn, Julian Hercun, Yao‐Chun Hsu, Ching‐Chih Hu, Jee‐Fu Huang, Naveed Z. Janjua, Jidong Jia, Martin Kåberg, Kelly Kaita, Habiba Kamal, Jia‐Horng Kao, Loreta A. Kondili, Martin Lagging, Pablo Lázaro, Jeffrey V. Lazarus, Mei‐Hsuan Lee, Young‐Suk Lim, Paul J. Marotta, María Cristina Navas, Marcelo Contardo Moscoso Naveira, Mauricio Orrego, Carla Osiowy, Calvin Q. Pan, Mário Guimarães Pessôa, Giovanni Raimondo, Alnoor Ramji, Devin Razavi‐Shearer, Kathryn Razavi‐Shearer, Cielo Ríos, Manuel Rodríguez, William Rosenberg, Dominique Roulot, Stephen Ryder, Rifaat Safadi, Faisal M. Sanai, Teresa Santantonio, Christoph Sarrazin, Daniel Shouval, Frank Tacke, Tammo Lambert Tergast, Juan Miguel Villalobos-Salcedo, Alexis Voeller, Hwai‐I Yang, Ming‐Lung Yu, Eli Zuckerman - Journal of Hepatology 2023 cited by 61

  20. Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Augusto Villanueva, Angelo Sangiovanni, Massimo Iavarone, Massimo Colombo, Josep M. Llovet, Aravind Subramanian, Andrew M. Tager, Scott L. Friedman, Thomas F. Baumert, Myron Schwarz, Raymond T. Chung, Kenneth K. Tanabe, Bin Zhang, Bryan C. Fuchs, Yujin Hoshida - Cancer Cell 2016 cited by 210

  21. Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2023 cited by 60

  22. Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2021 cited by 83

  23. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Bonham, Ming‐Lung Yu, Mindie H. Nguyen - Journal of Clinical Oncology 2024 cited by 50

  24. Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2022 cited by 40